Advanced cell-imaging platform for drug development.
MaxWell Biosystems AG
Incorporated
01.09.2016Headquarters
ZurichSupport
MaxWell Biosystems is a global leader providing advanced high-resolution functional cell imaging platforms to facilitate detailed investigation of cells. MaxOne (single-well) and MaxTwo (multi-well) allow stimulation and recording of every active cell on a dish at unprecedented spatio-temporal resolution. These instruments advance and accelerate drug discovery and basic neurosciences.
Every cell has a story to tell. MaxWell Biosystems aims to equip everyone with tools to easily observe, track, and discover cells' functionality, health, maturity, and response to compounds.
News
Maxwell Biosystems and 8inks on an international growth course (startupticker.ch)
Promising new tool for uncovering key characteristics of neurodegenerative diseases (startupticker.ch)
Credit Suisse investors and TOP 100 Startups connect over a table tennis tournament in Zurich (venturelab.swiss)
Loan guarantees for five startups (startupticker.ch)
MaxWell Biosystems obtains CHF 4 million in Series A financing round (startupticker.ch)
MaxWell Biosystems Completes CHF 4 million Series A Financing Round to further industrialize and scale-up (venturelab.swiss)
Finalisten des Entrepreneur Of The Year stehen fest (startupticker.ch)
Diese Startups sind am Final Pitch der Swiss Innovation Challenge dabei (startupticker.ch)
Three startups from three regions awarded at Venture Kick final (startupticker.ch)
Three startups from three regions awarded at Venture Kick final (startupticker.ch)
Ten startups in the finals of W. A. de Vigier Award (startupticker.ch)
Ten start-ups selected for the venture leaders Life Science program in Boston (startupticker.ch)
Ten start-ups selected for the venture leaders Life Science program in Boston (startupticker.ch)
Milestones news
Partner in a €3M EU-Financed Project “HyVIS”: Next Generation Prosthesis for Visual Restoration
Videos and Presentations
Company Video